Reviva Pharmaceuticals I... (RVPH)

1.44

0.01 (0.70%)

At close: Feb 28, 2025, 3:59 PM

1.45

1.05%

After-hours: Feb 28, 2025, 07:55 PM EST

Reviva Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-39.26M	-24.34M	-8.52M	-3.78M	-846.83K	-1.68M
Depreciation & Amortization	n/a	n/a	n/a	591.00	645.00	17.72K
Stock-Based Compensation	3.41M	176.74K	106.71K	n/a	n/a	21.05K
Other Working Capital	6.96M	2M	-203.71K	-3.1M	475.98K	541.98K
Other Non-Cash Items	239.22K	194.71K	-1.55M	2.39M	-6.41K	28.24K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	7.28M	5.01M	-702.17K	-2.33M	634.15K	541.98K
Operating Cash Flow	-28.32M	-18.96M	-10.67M	-3.73M	-218.44K	-1.07M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.68M	18.97K	98.48K	12.83M	n/a	175K
Financial Cash Flow	33.17M	7.79M	31.6M	12.83M	100K	175K
Net Cash Flow	4.85M	-11.17M	20.93M	8.76M	-118.44K	118.64K
Free Cash Flow	-28.32M	-18.96M	-10.67M	-3.73M	-218.44K	-1.07M